Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowSFG Quarterly Activities/Appendix 4CCash Flow Report
Just nowBSA Announces On-Market Share Buy-Back
Just nowPlacement
Just nowQ3 FY26 Activities Report and Appendix 4C
Just nowFY26 Q1 Quarterly Activities Report and Appendix 4C
Definium Therapeutics, Inc. logo

Definium Therapeutics, Inc.

About

Definium Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day
Apr 9 2026
Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
Mar 31 2026
New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States
Mar 30 2026
Definium Therapeutics Announces New Employee Inducement Grants
Mar 26 2026
Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026

Community Chat

Ask AI

6ix6ix